Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Goodall

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|March 21, 2015
Synthesis of improved lysomotropic autophagy inhibitorsTong Wang, Megan L Goodall, Paul Gonzales, et al.
The Pediatric Infectious Disease Journal|July 24, 2001
Timing and interpretation of tests for diagnosing perinatally acquired hepatitis C virus infectionD T Dunn, D M Gibb, M Healy, et al.
HIV Medicine|December 12, 2001
How generalizable are the results of large randomized controlled trials of antiretroviral therapy?D A Moore, R L Goodall, N J Ives, et al.
The Journal of Experimental Biology|July 9, 2025
Beetling the heat - the diurnal Namib Desert beetle Onymacris plana cools by runningCarole S Roberts, Elizabeth L McClain, Mary K Seely, et al.
Antiviral Therapy|May 17, 2007
A virological benefit from an induction/maintenance strategy: the Forte trialDavid Asboe, Ian G Williams, Ruth L Goodall, et al.
IJTLD Open|July 11, 2024
A publicly accessible global data repository - the WHO TB-IPD platformR L Goodall, S M Fabiane, A Hakiman, et al.
Trials|June 7, 2022
Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosisRuth L Goodall, Karen Sanders, Gay Bronson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 25, 2022
ECG monitoring in STREAM Stage 1: can we identify those at increased risk of QT prolongation?G Hughes, H Bern, C-Y Chiang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 30, 2022
QT prolongation in the STREAM Stage 1 TrialG Hughes, H Bern, C-Y Chiang, et al.
Tropical Medicine and Infectious Disease|September 27, 2024
Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary AnalysisStella M Fabiane, Chen-Yuan Chiang, Sarah K Meredith, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|March 21, 2015
Synthesis of improved lysomotropic autophagy inhibitorsTong Wang, Megan L Goodall, Paul Gonzales, et al.
The Pediatric Infectious Disease Journal|July 24, 2001
Timing and interpretation of tests for diagnosing perinatally acquired hepatitis C virus infectionD T Dunn, D M Gibb, M Healy, et al.
HIV Medicine|December 12, 2001
How generalizable are the results of large randomized controlled trials of antiretroviral therapy?D A Moore, R L Goodall, N J Ives, et al.
The Journal of Experimental Biology|July 9, 2025
Beetling the heat - the diurnal Namib Desert beetle Onymacris plana cools by runningCarole S Roberts, Elizabeth L McClain, Mary K Seely, et al.
Antiviral Therapy|May 17, 2007
A virological benefit from an induction/maintenance strategy: the Forte trialDavid Asboe, Ian G Williams, Ruth L Goodall, et al.
IJTLD Open|July 11, 2024
A publicly accessible global data repository - the WHO TB-IPD platformR L Goodall, S M Fabiane, A Hakiman, et al.
Trials|June 7, 2022
Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosisRuth L Goodall, Karen Sanders, Gay Bronson, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 25, 2022
ECG monitoring in STREAM Stage 1: can we identify those at increased risk of QT prolongation?G Hughes, H Bern, C-Y Chiang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 30, 2022
QT prolongation in the STREAM Stage 1 TrialG Hughes, H Bern, C-Y Chiang, et al.
Tropical Medicine and Infectious Disease|September 27, 2024
Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary AnalysisStella M Fabiane, Chen-Yuan Chiang, Sarah K Meredith, et al.
Pageof 9